Diakonos Oncology raised $11.4M in a seed round led by Restem Group Inc. to advance its dendritic cell vaccine into a Phase 2 clinical trial.
Amount Raised
$11.4 Million
Round Type
Seed
HoustonBiotechnologyHealth CareMedicalTherapeuticsInvestors
Description
Diakonos Oncology Corp. announced the final closing of an oversubscribed seed financing of $11.4 million, which will fund operations into late 2025 and support the initiation of a Phase 2 clinical trial for its lead asset, DOC1021. The round was led by Restem Group Inc. with participation from existing investors.
Quick answer
Diakonos Oncology raised $11.4 Million in a Seed round, dated August 26, 2024. Investors: Restem Group Inc. Diakonos Oncology is based in Houston, Texas, United States.
- How much did Diakonos Oncology raise?
- Diakonos Oncology raised $11.4 Million in a Seed round on August 26, 2024.
- Who invested in Diakonos Oncology?
- Restem Group Inc. is named as investors in this round.
- What does Diakonos Oncology do?
- Diakonos Oncology Corp. is a clinical stage immuno-oncology company based in Houston, TX.
- Where is Diakonos Oncology based and how big is it?
- Diakonos Oncology is based in Houston, Texas, United States. Fundz records about 17 employees.
- Who are the decision-makers at Diakonos Oncology?
- Fundz holds 1 contact at Diakonos Oncology. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Diakonos Oncology that raised within 45 days of this round, from Fundz verified event records.
- MONCYTE Health raised $1.1M (Seed) on October 8, 2024.
- CorFlow Therapeutics AG raised $49M (Series B) on September 10, 2024.
- TippingPoint Biosciences raised an undisclosed amount (Pre-Seed) on September 5, 2024.
- Lipella Pharmaceuticals raised $120K on July 31, 2024.
- Scorpion Therapeutics raised $150M (Series C) on July 16, 2024.
- Booster Therapeutics raised $15M (Angel) on October 10, 2024.
Who to call at Diakonos Oncology, and when
A new round usually means Diakonos Oncology is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Diakonos Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Diakonos Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Diakonos Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Diakonos Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Diakonos Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.